Skip to main content

Advertisement

Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia

Fig. 1

Mean concentrations of EPA (panel a), DHA (panel b) and DPA (panel c) in plasma and omega-3 index in erythrocytes (panel d) in the control (dotted lines) and treated (unbroken lines) groups during the 12-week treatment (weeks 0-12) followed by 8 weeks wash-out (weeks 12-20). Vertical lines indicate SEM for each data-point. Dose-levels at the bottom of the graph refer to phospholipid doses

Back to article page